Cosmo Bio Co (TSE:3386) FCF Margin %: -5.98% (As of Dec. 2025)

What is Cosmo Bio Co FCF Margin %?

Cosmo Bio Co TSE:3386 -0.55% 73 FCF Margin % is -5.98% as of Dec. 2025. GuruFocus rates TSE:3386 with a GF Score™ of 73/100 and a GF Value™ of 円1,246.90 (Fairly Valued). The stock has 4 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Cosmo Bio Co ranks better than 57.84% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Cosmo Bio Co's Free Cash Flow for the six months ended in Dec. 2025 was 円-321 Mil. Cosmo Bio Co's Revenue for the six months ended in Dec. 2025 was 円5,364 Mil. Therefore, Cosmo Bio Co's FCF Margin % for the quarter that ended in Dec. 2025 was -5.98%.

As of today, Cosmo Bio Co's current FCF Yield % is 4.38%.

The historical rank and industry rank for Cosmo Bio Co's FCF Margin % or its related term are showing as below:

TSE:3386' s FCF Margin % Range Over the Past 10 Years
Min: -6.3 Med: 4.75 Max: 10.58
Current: 2.92

During the past 13 years, the highest FCF Margin % of Cosmo Bio Co was 10.58%. The lowest was -6.30%. And the median was 4.75%.

TSE:3386's FCF Margin % is ranked better than
57.84% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: -1.845 vs TSE:3386: 2.92

Cosmo Bio Co FCF Margin % Related Terms

Cosmo Bio Co FCF Margin % Historical Data

* Premium members only.

The historical data trend for Cosmo Bio Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cosmo Bio Co FCF Margin % Chart

Cosmo Bio Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

FCF Margin %

Get a 7-Day Free Trial

5.49

1.88

6.81

-0.35

2.92

Cosmo Bio Co Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
FCF Margin %	Get a 7-Day Free Trial															-3.37	4.25	-5.15	11.75	-5.98

TSE:3386 vs TMO, DHR, IDXX: FCF Margin % Comparison

For the Diagnostics & Research subindustry, Cosmo Bio Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cosmo Bio Co FCF Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Cosmo Bio Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Cosmo Bio Co's FCF Margin % falls into.

Save Embed

73GF Score

Cosmo Bio Co Ltd TSE:3386

FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Cosmo Bio Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Cosmo Bio Co's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	314	/	10766
	=	2.92 %

Cosmo Bio Co's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2025 )	/	Revenue (Q: Dec. 2025 )
	=	-321	/	5364
	=	-5.98 %

Frequently Asked Questions Learn more about FCF Margin % →

What does a FCF Margin % of -5.98% mean?

Cosmo Bio Co (TSE:3386) has a FCF Margin % of -5.98% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Cosmo Bio Co and its competitors. According to the industry distribution chart, Cosmo Bio Co ranks #86 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 42.2%.

Is Cosmo Bio Co's FCF Margin % too high?

Cosmo Bio Co's current FCF Margin % is -5.98%. Based on the distribution chart, Cosmo Bio Co ranks #86 out of 204 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Cosmo Bio Co has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Cosmo Bio Co's FCF Margin % compare to TMO and DHR?

According to the Medical Diagnostics & Research industry distribution chart, Cosmo Bio Co ranks #86 out of 204 companies for FCF Margin %. This puts Cosmo Bio Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good FCF Margin % for a Medical Diagnostics & Research company?

A good FCF Margin % depends on the Medical Diagnostics & Research industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high FCF Margin % mean?

A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Cosmo Bio Co and its competitors. Cosmo Bio Co's current FCF Margin % is -5.98%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Cosmo Bio Co stock overvalued right now?

Based on GuruFocus' analysis, Cosmo Bio Co (TSE:3386) is currently considered Fairly Valued. The stock's GF Value™ is 円1,246.90, compared to a current price of 円1,262.00 — trading 1.2% above its estimated fair value. The current FCF Margin % is -5.98%. Cosmo Bio Co's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is FCF Margin % calculated?

FCF Margin % is calculated from a company's financial statements. For Cosmo Bio Co (TSE:3386), the current FCF Margin % is -5.98% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cosmo Bio Co (TSE:3386) Overvalued in 2026?

Based on GuruFocus' analysis, Cosmo Bio Co stock appears to be overvalued. The current stock price of 円1,262.00 is trading 1.2% above its estimated GF Value™ of 円1,246.90. GuruFocus considers Cosmo Bio Co to be Fairly Valued.

Key valuation signals for TSE:3386:

FCF Margin %: -5.98%
GF Value™: 円1,246.90 vs. price of 円1,262.00 (1.2% above fair value)
GF Score™: 73/100 with 4 warning signs

No single metric tells the full story. See the TSE:3386 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cosmo Bio Co Business Description

Industry Healthcare Medical Diagnostics & Research

Comparable Companies TSE:6090 TSE:4671 TMO DHR SHSE:603259 XSWX:LONN IDXX A NTRA WAT IQV ILMN MTD DGX LH GH MEDP XPAR:ERF ICLR RVTY

Address 2-20, Toyo-Ekimae Building, Toyo 2-Chome, Koto-ku, Tokyo, JPN, 135-0016

Website http://www.cosmobio.co.jp

Cosmo Bio Co Ltd is a diagnostic and research company based in Japan. The business of the company includes the purchase of reagents, instruments, and clinical test drugs for research in life science and domestic sales.

73GF Score

Get the complete analysis for TSE:3386

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,262.00

Price

円1,246.90

GF Value

View TSE:3386 Analysis

See FCF Margin % data for all stocks →